The Food and Drug Administration is preparing to clear two batches of Johnson & Johnson Covid-19 vaccines that were produced at the troubled Emergent facility in Baltimore, a source familiar with the plans told CNN.
Top Investments for 2025: A Focus on the S&P 500
As we move into 2025, the S&P 500 continues to be a cornerstone of investment strategies, offering insights into the U.S. stock market’s health. Following